Mail

Canada markets close in 14 minutes

S&P/TSX
22,111.34
+39.63(+0.18%)
S&P 500
5,246.13
+10.65(+0.20%)
DOW
38,470.52
+359.04(+0.94%)
CAD/USD
0.7337
+0.0026(+0.36%)
CRUDE OIL
77.10
-0.81(-1.04%)
Bitcoin CAD
92,304.49
-1,306.64(-1.40%)

MARKETS LIVE BLOG

STOCKS MIXED AS CLOSELY WATCHED U.S. CPI MEASURE SLOWS

Fed's stance of higher for longer likely not shaken by new inflation reading

Leap Therapeutics Inc (5MC.BE)

Berlin - Berlin Delayed Price. Currency in EUR

Add to watchlist

2.2400

+0.0800

(+3.70%)

As of 08:21PM CEST. Market open.

Previous Close	2.1600
Open	2.1800
Bid	2.1400 x N/A
Ask	2.3400 x N/A
Day's Range	2.1200 - 2.2400
52 Week Range	1.2100 - 8.7000
Volume	N/A
Avg. Volume	0

Market Cap	N/A
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

News

GuruFocus.com
Leap Therapeutics Inc (LPTX) Q1 2024 Earnings: Financial Resilience Amidst Clinical Progress
Significant Reduction in Net Loss and Strategic Clinical Advancements
Zacks
Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.